Nature Publishing Group

SHERPA: Yellow

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Al-Ahmadie
    Al-Ahmadie
  4. Fine
    Fine
  5. Gopalan
    Gopalan
  6. Tickoo
    Tickoo
  7. Antonescu
    Antonescu
  8. Shia
    Shia
  9. Chen
    Chen
  10. Weigelt
    Weigelt

Groups

  1. GSK Faculty (2499)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1422)
  5. Sloan Kettering Institute Postdocs (1260)
  6. Center for Hematologic Malignancies (1096)
  7. Hematologic Malignancies, Division of (1002)
  8. Solid Tumor Oncology Division (990)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (964)
  10. Tow Center for Developmental Oncology (TCDO) (891)
Search Within
Formats
  1. Journal Article (3659)
  2. Meeting Abstract (2162)
  3. Review (191)
  4. Editorial (102)
  5. Research Letter (96)
  6. Correspondence (32)
  7. Conference Paper (23)
  8. Guidelines (13)
  9. Miscellaneous (9)
Groups
  1. GSK Faculty (2499)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1422)
  5. Sloan Kettering Institute Postdocs (1260)
  6. Center for Hematologic Malignancies (1096)

More Groups

People
  1. Victor Reuter (297)
  2. Marc Ladanyi (225)
  3. Hikmat Al-Ahmadie (197)
  4. David Klimstra (195)
  5. Robert Soslow (165)
  6. Samson Fine (159)

More People

Years
  1. 2025 (327)
  2. 2024 (365)
  3. 2023 (326)
  4. 2022 (355)
  5. 2021 (316)
  6. 2020 (375)

More Years

Publications
  1. Laboratory Investigation (1890)
  2. Nature (604)
  3. Nature Communications (453)
  4. Bone Marrow Transplantation (381)
  5. Leukemia (283)
  6. Nature Medicine (249)

More Publications

Results (6287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Sarcoma classification by DNA methylation profiling
    Journal Article

    Koelsche, C.; Schrimpf, D.; Stichel, D.; Sill, M.; Sahm, F.; Reuss, D. E.; Blattner, M.; Worst, B.; Heilig, C. E.; Beck, K.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Risk of infections in patients with myeloproliferative neoplasms - A population-based cohort study of 8363 patients
    Journal Article

    Landtblom, A. R.; Andersson, T. M. L.; Dickman, P. W.; Smedby, K. E.; Eloranta, S.; Batyrbekova, N.; Samuelsson, J.; Björkholm, M.; Hultcrantz, M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic hedgehog-medulloblastoma model
    Journal Article

    Tan, I. L.; Arifa, R. D. N.; Rallapalli, H.; Kana, V.; Lao, Z.; Sanghrajka, R. M.; Bayin, N. S.; Tanne, A.; Wojcinski, A.; Korshunov, A.; more...
    Oncogene (2021)

    Fulltext@MSK | Save
  • Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture
    Journal Article

    Yusufova, N.; Kloetgen, A.; Teater, M.; Osunsade, A.; Camarillo, J. M.; Chin, C. R.; Doane, A. S.; Venters, B. J.; Portillo-Ledesma, S.; Conway, J.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • H1 histones control the epigenetic landscape by local chromatin compaction
    Journal Article

    Willcockson, M. A.; Healton, S. E.; Weiss, C. N.; Bartholdy, B. A.; Botbol, Y.; Mishra, L. N.; Sidhwani, D. S.; Wilson, T. J.; Pinto, H. B.; Maron, M. I.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Research Letter

    Lee, H. C.; Raje, N. S.; Landgren, O.; Upreti, V. V.; Wang, J.; Avilion, A. A.; Hu, X.; Rasmussen, E.; Ngarmchamnanrith, G.; Fujii, H.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: Indication for prognostication and clinical decision-making
    Journal Article

    Chen, S. Y.; Yang, Y.; Qi, S. N.; Wang, Y.; Hu, C.; He, X.; Zhang, L. L.; Wu, G.; Qu, B. L.; Qian, L. T.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
    Review

    Costa, L. J.; Derman, B. A.; Bal, S.; Sidana, S.; Chhabra, S.; Silbermann, R.; Ye, J. C.; Cook, G.; Cornell, R. F.; Holstein, S. A.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: Results from a multicenter, randomized, phase 2/3 study
    Journal Article

    Montesinos, P.; Roboz, G. J.; Bulabois, C. E.; Subklewe, M.; Platzbecker, U.; Ofran, Y.; Papayannidis, C.; Wierzbowska, A.; Shin, H. J.; Doronin, V.; more...
    Leukemia (2021)

    Fulltext@MSK | Save